News

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...
Cell division is an essential biological process that removes aged cells and continuously renews tissues. In the human body, billions of cells divide each day: intestinal cells are completely renewed ...
In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Among the sector ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...
Explore more
The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't ...